Disseminated varicella zoster virus infection with encephalitis in a UC patient receiving infliximab

Gastroenterology and Hepatology

Volumn 9, Issue 1, 2013, Pages

  Elwir, Saleh M ^a   Shaffer, Christopher C ^a   Arvan, Susan W ^a   Kuperman, Ethan F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; INFLIXIMAB;

AGED; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID CULTURE; DISEASE DURATION; DNA VIRUS; DRUG INFUSION; EMERGENCY WARD; ENCEPHALITIS; ERYTHEMA; FEVER; HERPES ZOSTER; HOSPITAL DISCHARGE; HUMAN; MAINTENANCE THERAPY; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; POSTHERPETIC NEURALGIA; TACHYCARDIA; TREATMENT DURATION; ULCERATIVE COLITIS; UNSTEADY GAIT; VESICULAR RASH; VIRUS DETECTION; WEAKNESS;

EID: 84878439892     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929-936. (Pubitemid 351451967)
2. Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008;26:675-697, viii. (Pubitemid 352020491)
3. Baumgart DC, Dignass AU. Shingles following infliximab infusion. Ann Rheum Dis. 2002;61:661.
4. Serac G, Tubach F, Mariette X, et al. Risk of herpes zoster in patients receiving anti-TNF-alpha in the prospective French RATIO registry. J Invest Dermatol. 2012;132:726-729.
5. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30; quiz CE2-CE4.
6. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635-645. (Pubitemid 30118417)
7. Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci. 2002;195:99-101. (Pubitemid 34202285)
8. Strangfeld A, Listing J, Herzer P, et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009;301:737-744.
9. Garcia-Doval I, Perez-Zafrilla B, Descalzo MA, et al; BIOBADASER 2.0 Study Group. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis. 2010;69:1751-1755.
10. Buccoliero G, Lonero G, Romanelli C, Loperfido P, Resta F. Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient. New Microbiol. 2010;33:271-274.
11. Keystone EC, Kavanaugh AF, Sharp JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum. 2004;50:1400-1411. (Pubitemid 38608061)
12. Oxman MN, Levin MJ, Johnson GR, et al Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-2284.
13. Curtis KK, Connolly MK, Northfelt DW. Live, attenuated varicella zoster vaccination of an immunocompromised patient. J Gen Intern Med. 2008;23:648-649.
14. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008;197(suppl 2):S165-S169. (Pubitemid 351590166)
15. Zhang J, Delzell E, Xie F, et al. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res Ther. 2011;13:R174.
16. Agarwal N, Ollington K, Kaneshiro M, Frenck R, Melmed GY. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine. 2012;30:1413-1424.
17. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105:1231-1238.
18. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101:1834-1840. (Pubitemid 44166594)
19. Yeung JH, Goodman KJ, Fedorak RN. Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis. 2012;18:34-40.